Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB 1 receptors

By Landi M.   Croci T.   Rinaldi-Carmona M.   Maffrand J.-P.   Le Fur G.   Manara L.  

European Journal of Pharmacology, Vol. 450, Iss. 1, 2002-08 ,pp. : 77-83

Elsevier

Access to resources Recommend Favorite

Compounds possessing 5-HT 3 receptor antagonistic activity inhibit intestinal propulsion in mice

By Nagakura Y.   Naitoh Y.   Kamato T.   Yamano M.   Miyata K.  

European Journal of Pharmacology, Vol. 311, Iss. 1, 1996-09 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

Relationship between Cannabinoid CB₁ and Dopamine D₂ Receptors in Intestinal Motility in Mice

By Carai M.A.M.   Agabio R.   Lobina C.   Pani M.   Reali R.   Vacca G.   Colombo G.   Gessa G.L.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 287-291

Pharmaceutical Press

Access to resources Recommend Favorite

Cannabinoid Modulation of Neuroinflammatory Disorders

By  

Current Neuropharmacology, Vol. 10, Iss. 2, 2012-06 ,pp. : 159-166

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands

By Smith S.R.   Terminelli C.   Denhardt G.  

European Journal of Pharmacology, Vol. 425, Iss. 1, 2001-08 ,pp. : 73-83

Elsevier

Access to resources Recommend Favorite